Truthdig In a news release last week, the department said the company paid physicians to talk about three Novartis medications—hypertension drugs amlodipine/benazepril (Lotrel) and aliskiren/ valsartan (Valturna) and diabetes drug nateglinide (Starlix). The ... and more »
